Out-licensing
Up-to-date access to technology licensing opportunities worldwide.
- Out-licensing
- Browse
Licensing opportunities
4 and 8 mg Ondansetron ready for submission in EU (exp. Q4/08) using the proprietary RapidFilm drug delivery Technology securing fast dissolution in the oral cavity without the need of water More
Gene targeting and localized delivery of anti-neoplastic agents More
Disruption of transmembrane domain interactions More
The three-chamber ‘Combiflex’ lipid bag provides a key source of glucose, amino acid solutions and fat emulsions to patients and children over the age of 2 who are unable to administer nutrition through the oral or enteral route. More
Related Reports
Market Research Reports provided by reports.innovaro.com
Nov 2009 - $15,200
Dec 2010 - 19 pages - $99
Jul 2011 - 132 pages - $500
Nov 2010 - 26 pages - $125
Dec 2010 - 21 pages - $500
Dec 2010 - 40 pages - $500
Mar 2011 - 40 pages - $500
May 2011 - 15 pages - $250
Nov 2010 - 40 pages - $500
Mar 2011 - 33 pages - $125
Your selection
Browse By
- Industry sector
- Animal health
- Biotechnology
- Diagnostic
- Drug delivery
- Drug discovery
- Medical device
- Pharmaceutical
- Research tools
- Development phase
- Early Stage
- Preclinical
- Phase I
- Phase I/II
- Phase II
- Phase III
- Phase III/IV
- Preregistration
- Registered
© Copyright 1998-2012 Innovaro Europe Ltd 
All rights reserved. Terms and Conditions | Contact us